| Date Filed | Type | Description |
| 05/19/2023 |
4
| Mulligan Richard (Director) has filed a Form 4 on Bausch Health Companies Inc.|
Txns:
| Granted 29,205 shares
@ $0 |
|
| 06/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/12/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/05/2020 |
4
| Mulligan Richard (Director) has filed a Form 4 on BIOGEN INC.|
Txns:
| Granted 890 shares
@ $0 |
|
| 06/20/2019 |
4
| Mulligan Richard (Director) has filed a Form 4 on BIOGEN INC.|
Txns:
| Granted 1,155 shares
@ $0 |
|
| 06/14/2018 |
4
| Mulligan Richard (Director) has filed a Form 4 on BIOGEN INC.|
Txns:
| Granted 880 shares
@ $0 |
|
| 06/09/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/09/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/11/2015 |
4
| Mulligan Richard (Director) has filed a Form 4 on BIOGEN INC.|
Txns:
| Granted 695 shares
@ $0 |
|
| 06/16/2014 |
4
| Mulligan Richard (Director) has filed a Form 4 on BIOGEN IDEC INC.|
Txns:
| Granted 870 shares
@ $0 |
|
| 06/13/2013 |
4
| Mulligan Richard (Director) has filed a Form 4 on BIOGEN IDEC INC.|
Txns:
| Granted 1,305 shares
@ $0 |
|
| 05/31/2013 |
4
| Mulligan Richard (Director) has filed a Form 4 on BIOGEN IDEC INC.|
Txns:
| Exercised 3,000 shares
@ $53.43, valued at
$160.3k
Exercised 3,000 options to buy
@ $0
Exercised 3,000 shares
@ $53.43, valued at
$160.3k
Exercised 3,000 options to buy
@ $0 |
|
| 05/29/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/25/2013 |
4
| Mulligan Richard (Director) has filed a Form 4 on BIOGEN IDEC INC.|
Txns:
| Sold 2,900 shares
@ $176.88, valued at
$513k
|
|
| 03/13/2013 |
4
| Mulligan Richard (Director) has filed a Form 4 on BIOGEN IDEC INC.|
Txns:
| Sold 2,980 shares
@ $174.7497, valued at
$520.8k
Sold 5,000 shares
@ $175.7545, valued at
$878.8k
|
|
| 01/04/2013 |
4
| Mulligan Richard (Director) has filed a Form 4 on ENZON PHARMACEUTICALS INC|
Txns:
| Granted 35,226 options to buy
@ $4.54, valued at
$159.9k
|
|
| 07/03/2012 |
4
| Mulligan Richard (Director) has filed a Form 4 on ENZON PHARMACEUTICALS INC|
Txns:
| Granted 18,670 shares
@ $0 |
|
| 06/11/2012 |
4
| Mulligan Richard (Director) has filed a Form 4 on BIOGEN IDEC INC.|
Txns:
| Granted 2,020 shares
@ $0 |
|
| 01/05/2012 |
4
| Mulligan Richard (Director) has filed a Form 4 on ENZON PHARMACEUTICALS INC|
Txns:
| Granted 19,240 options to buy
@ $6.81, valued at
$131k
|
|
| 07/06/2011 |
4
| Mulligan Richard (Director) has filed a Form 4 on ENZON PHARMACEUTICALS INC|
Txns:
| Granted 12,919 shares
@ $0 |
|
| 06/02/2011 |
4
| Mulligan Richard (Director) has filed a Form 4 on BIOGEN IDEC INC.|
Txns:
| Granted 2,900 shares
@ $0 |
|
| 01/05/2011 |
4
| Mulligan Richard (Director) has filed a Form 4 on ENZON PHARMACEUTICALS INC|
Txns:
| Granted 16,996 options to buy
@ $12.4, valued at
$210.8k
|
|
| 07/06/2010 |
4
| Mulligan Richard (Director) has filed a Form 4 on ENZON PHARMACEUTICALS INC|
Txns:
| Granted 7,043 shares
@ $0 |
|
| 06/10/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/06/2010 |
4
| Mulligan Richard (Director) has filed a Form 4 on ENZON PHARMACEUTICALS INC|
Txns:
| Granted 16,787 options to buy
@ $10.73, valued at
$180.1k
|
|
| 06/11/2009 |
4
| Mulligan Richard (Director) has filed a Form 4 on BIOGEN IDEC INC. |
| 06/11/2009 |
3
| Mulligan Richard (Director) has filed a Form 3 on BIOGEN IDEC INC. |
| 05/26/2009 |
4
| Mulligan Richard (Director) has filed a Form 4 on ENZON PHARMACEUTICALS INC |
| 05/26/2009 |
3
| Form 3 -- Initial statement of beneficial ownership of securities |